🇺🇸 FDA
Patent

US 11891360

Glycosylated psilocybin derivatives and methods of using

granted A61PA61P25/00

Quick answer

US patent 11891360 (Glycosylated psilocybin derivatives and methods of using) held by Enveric Biosciences Canada Inc. expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enveric Biosciences Canada Inc.
Grant date
Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P25/00